chevron_leftBack
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
300534
9.47CNY
0%
1.40 USD
As of 15 June 2026, Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD has a market cap of $423.95M USD, ranking #16274 globally and #5104 in China.
It ranks #1468 in the Healthcare sector, and #532 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$423.95MUSD
2.87B CNY
Enterprise Value
$419.14MUSD
2.84B CNY
Revenue (TTM)
$130.9MUSD
886.96M CNY
EBITDA (TTM)
$19.09MUSD
129.18M CNY
Net Income (TTM)
$6.49MUSD
43.95M CNY
EBITDA Margin
15%
Profit Margin
5%
PE Ratio
65.4
PS Ratio
3.2
PB Ratio
3.7
EV/EBITDA
21.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yue Hong Song
open_in_new
Employees
641
Founded
2002
Website
lsrfzy.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 3.5% | 1.5% | -5.5% | -5.3% | 5% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300534
甘肃陇神戎发药业股份有限公司 Class A
ISIN: CNE100002CP5
Shares Out.:
Shares Outstanding:
303.345M1
Shares Float:
282.021M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
9.47 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and is based in Lanzhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
13K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
12K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
7K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
4K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
4K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
4K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
180K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
129K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
85K%
|
97.4
|
|
SIX: RO
|
$321.52B
76K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
68K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
65K%
218.9B CHF
|
20.5
|
chevron_leftBack